Angiotensin receptor neprilysin inhibition in reduced ejection fraction patients with advanced chronic kidney disease: a multicenter propensity score matching study
Event:
Heart Failure 2022
Topic:
Heart Failure with Reduced Ejection Fraction (HFrEF)
Twin peaks diversity with sacubitril/valsartan treatment responses in cardiomyopathic heart failure patients of non-ischemic compared to ischemic etiologies
Sacubitril/valsartan in heart failure with reduced ejection fraction patients: real world experience on advanced chronic kidney disease, hypotension and dose titration
Twin peaks diversity with sacubitril/valsartan treatment responses in cardiomyopathic heart failure patients of non-ischemic compared to ischemic etiologies